China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase ...(rt on Form 20-Ffor the year ended March ...),Health
Navigation Links
China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
Date:8/11/2008
rt on Form 20-F for the year ended March 31, 2008.
For more information, please contact:
Sam Tsang
Tel: +86-10-6530-8833
Email: IR@chinameditech.com
'/>"/>
| SOURCE China Medical Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger
2. China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
3. UNC School of Social Work helps China tackle growing pains
4. Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics
5. China Shenghuo Pharmaceutical Retains Grayling Global As Investor Relations Counsel
6. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
7. China Medicine Corporation Obtains Australian Patent for rADTZ
8. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
9. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
10. Closing coal-burning power plant in China and improved cognitive development in children
11. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
Post Your Comments:
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5
[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[1] Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight'[1] VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution[0] Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health[0] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management
Other Medicine News:Health News:Rise in the death rates among the British due to alcohol intake. 2
Officials In Turkey Confirm Deaths Due To Bird FluRise in the death rates among the British due to alcohol intake.Rogue Mammary Stem Cells Could Hold Key To Breast Cancer RelapseHIV/AIDS Throws Family Relationships Out Of Gear In UgandaThe HIV Bug infects and alarms BeijingAlzheimer's Can Be Slowed Down By Gold Nanoparticles
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices 5082 1Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices 5082 2Clearly Contacts Director of Web Sales Named as One of Canada 26apos 3Bs Top Online Marketers of 2009 58502 1Clearly Contacts Director of Web Sales Named as One of Canada 26apos 3Bs Top Online Marketers of 2009 58502 2Oakstone Medical Publishing Introduces an Online ABR Qualified Self Assessment Module for Radiologists Designed to Satisfy MOC Requirements 58497 1Oakstone Medical Publishing Introduces an Online ABR Qualified Self Assessment Module for Radiologists Designed to Satisfy MOC Requirements 58497 2
[0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program[0] CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition[0] Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
Other Medicine Technology:Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 2Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 3EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 2EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 3EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |